Set Patient Expectations for Home Genetic Tests
July 2018
Patients will ask you about direct-to-consumer genetic tests for diseases...now that FDA allows marketing of 23andMe genetic risk tests.
The 23andMe tests analyze specific gene markers linked to conditions such as Alzheimer's, breast cancer, celiac disease, and Parkinson's.
This will pave the way for more home genetic tests to go beyond providing ancestry info. And it's different than pharmacogenetic testing that tailors drugs and doses based on a patient's genes.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote